FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / Deal Tables / Deal List / Deal Details

The ABL Advisor Deal Tables

SELECTED TRANSACTION DETAILS
Avenue Capital Group Provides $18MM Growth Capital Facility to Epica International
Friday, September 20, 2024

Lenders/Participants Avenue Capital [Lender]
Structure Growth Capital Facility
Amount $18.000 Million
Borrower(s) Epica International Inc.
Description The initial funding of $13.5 million will be used to refinance existing debt, support strategic expansion, and accelerate research and development initiatives. An additional $4.5 million is available in tranches upon the achievement of specific performance milestones. The growth capital loan has a four-year term and includes provisions for Avenue Capital to receive a 0.5% equity stake in Epica International, with an option to invest an additional $2 million in equity within two years. The lender also has the right to convert up to $3.5 million of their principal into common stock at a price of $8.50 per share.
Industry Medical
Location SC
Related Tags Avenue Capital Group